Chemical Structure (Inqovi 01)
Inqovi Tablet, Film Coated
Product Images NDC 64842-0727
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Inqovi (NDC 64842-0727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Taiho Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Inqovi 02)
Principal Display Panel (35 mg/100 mg Tablet Carton)
This is a description of a hazardous drug called INQOVI, which is available only through prescription. INQOVI contains decitabine and cedazuriding and comes in tablet form, with each tablet containing 35 mg/100 mg of these compounds. The packaging contains instructions for use, including the caution that it is a hazardous agent. The text also includes a National Drug Code (NDC) identifier. Additionally, the text contains some unrelated characters, possibly from an instruction manual, and cannot be understood.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
